The greatest obstacle to using drugs to treat brain tumors is the blood‐brain barrier (BBB),
making it difficult for conventional drug molecules to enter the brain. Therefore, how to safely …

Natural living materials serving as biotherapeutics exhibit great potential for treating various
diseases owing to their immunoactivity, tissue targeting, and other biological activities. In this …

Bacteriophages (phages) are nanostructured viruses with highly selective antibacterial
properties that have gained attention beyond eliminating bacteria. Specifically, M13 phages …

Viruses are changing the biosensing and biomedicine landscape due to their multivalency,
orthogonal reactivities, and responsiveness to genetic modifications. As the most extensively …

M13 phages possessing filamentous phage genomes offer the benefits of selective display
of molecular moieties and delivery of therapeutic agent payloads with a tolerable safety …

Direct delivery of therapeutic genes is a promising approach for treating cancers and other
diseases. The current human viral vectors, however, suffer from several drawbacks …

Phage display enables to screen probes such as peptide, antibody and nanobody with high
specificity and affinity to the target, providing excellent probes for various analytical or …

Bacteriophages (phages) represent a unique category of viruses with a remarkable ability to
selectively infect host bacteria, characterized by their assembly from proteins and nucleic …

The effective isolation of rare target cells, such as circulating tumor cells, from whole blood is
still challenging due to the lack of a capturing surface with strong target-binding affinity and …

Glioblastoma (GBL) is the most common (60–70% of primary brain tumours) and the most
malignant of the glial tumours. Although current therapies remain palliative, they have been …